We are live on ! Find out more
PFM

Privium Fund Management Portfolio holdings

AUM $480M
1-Year Est. Return 77.45%
This Fund
S&P 500
This Quarter Est. Return
+31.78%
1 Year Est. Return
+77.45%
3 Year Est. Return
+410.34%
5 Year Est. Return
10 Year Est. Return
AUM
$464M
AUM Growth
+$79.9M
Cap. Flow
-$8.95M
Cap. Flow %
-1.93%
Top 10 Hldgs %
81.5%
Holding
63
New
7
Increased
24
Reduced
7
Closed
8

Top Buys

Rank Stock Value
1
COIN icon
Coinbase
COIN
+$16.4M
2
TSLA icon
Tesla
TSLA
+$6.63M
3
BIIB icon
Biogen
BIIB
+$2.55M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$1.68M
5
AMZN icon
Amazon
AMZN
+$1.58M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$19.9M
2
SNOW icon
Snowflake
SNOW
+$7.13M
3
NET icon
Cloudflare
NET
+$6.76M
4
SWTX
SpringWorks Therapeutics
SWTX
+$5.47M
5
CPNG icon
Coupang
CPNG
+$1.83M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 30.56%
2 Technology 23.32%
3 Healthcare 20.84%
4 Communication Services 18.3%
5 Financials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROIV icon
26
Roivant Sciences
ROIV
$24.3B
$1.39M 0.3%
126,923
RNAM
27
DELISTED
Avidity Biosciences
RNAM
$1.31M 0.28%
46,000
+11,500
+33% +$343K
KRYS icon
28
Krystal Biotech
KRYS
$10.7B
$1.3M 0.28%
9,320
+1,810
+24% +$266K
BNTX icon
29
BioNTech
BNTX
$23.4B
$1.18M 0.25%
+10,987
New +$1.11M
RCKT icon
30
Rocket Pharmaceuticals
RCKT
$343M
$1.12M 0.24%
432,760
HIMS icon
31
Hims & Hers Health
HIMS
$6.79B
$1.1M 0.24%
+22,000
New +$994K
MGTX icon
32
MeiraGTx Holdings
MGTX
$1.09B
$1.06M 0.23%
163,000
+46,000
+39% +$272K
PFE icon
33
Pfizer
PFE
$144B
$927K 0.2%
37,029
+4,702
+15% +$110K
WVE icon
34
Wave Life Sciences
WVE
$1.13B
$884K 0.19%
135,550
+22,000
+19% +$145K
PAAS icon
35
Pan American Silver
PAAS
$18.2B
$845K 0.18%
29,747
+8,463
+40% +$219K
NOV icon
36
NOV
NOV
$7.11B
$825K 0.18%
63,876
+14,131
+28% +$178K
FDMT icon
37
4D Molecular Therapeutics
FDMT
$515M
$819K 0.18%
197,458
+66,458
+51% +$234K
URNM icon
38
Sprott Uranium Miners ETF
URNM
$1.75B
$761K 0.16%
16,278
+4,164
+34% +$158K
LXEO icon
39
Lexeo Therapeutics
LXEO
$345M
$753K 0.16%
178,356
+18,158
+11% +$59.7K
VZLA
40
Vizsla Silver
VZLA
$1.12B
$732K 0.16%
250,790
+58,303
+30% +$152K
SRPT icon
41
Sarepta Therapeutics
SRPT
$1.63B
$698K 0.15%
+39,400
New +$1.68M
AUTL
42
Autolus Therapeutics
AUTL
$386M
$674K 0.15%
294,142
+42,468
+17% +$70.2K
SA
43
Seabridge Gold
SA
$2.69B
$648K 0.14%
44,074
RXRX icon
44
Recursion Pharmaceuticals
RXRX
$1.62B
$610K 0.13%
119,000
VAL icon
45
Valaris
VAL
$5.16B
$606K 0.13%
13,803
-6,419
-32% -$241K
EMX
46
DELISTED
EMX Royalty
EMX
$545K 0.12%
216,968
SD icon
47
SandRidge Energy
SD
$485M
$401K 0.09%
37,022
+13,722
+59% +$140K
NE icon
48
Noble Corp
NE
$6.25B
$392K 0.08%
14,287
TSHA icon
49
Taysha Gene Therapies
TSHA
$1.57B
$316K 0.07%
134,900
TDW icon
50
Tidewater
TDW
$3.71B
$255K 0.06%
+5,350
New +$217K

Similar funds

Privium Fund Management's Q2 2025 Portfolio in Review

As of Q2 2025, Privium Fund Management held 63 positions worth $464M, up 21% from $384M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Privium Fund Management's Q2 2025 filing shows 7 new, 24 increased, 7 reduced and 8 closed positions. Its largest new stake was Coinbase: 70,000 shares worth $24.2M. The largest sale was Spotify, an estimated $19.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 31% of assets, up from 30% a quarter earlier, followed by Technology and Healthcare.

  • Privium Fund Management's largest Q2 2025 buy was Coinbase: 70,000 shares worth $24.2M.
  • Privium Fund Management added most to Tesla in Q2 2025, an estimated $6.63M increase.
  • Privium Fund Management's biggest Q2 2025 reduction was Spotify, cutting an estimated $19.9M.
  • Privium Fund Management fully exited Snowflake in Q2 2025, selling an estimated $7.13M.
  • Privium Fund Management's ten largest holdings make up 82% of its $464M portfolio in Q2 2025.
  • Privium Fund Management opened 7 new positions and closed 8 in Q2 2025.
  • Privium Fund Management's portfolio value rose 21% quarter-over-quarter to $464M.

Based on Privium Fund Management's 13F filing for Q2 2025, filed 30 Jul 2025.